Orthofix Cervical-Stim PMA Filing Almost Complete; Firm Settles With TriCare

Regulations governing TriCare coverage policies do not prohibit reimbursement of FDA-approved products for off-label uses, Orthofix maintains, despite paying $1.7 mil. in a billing investigation settlement with the Department of Justice